Nippon Shinyaku (OTCPK:NPNK.F) - Stock Price, News & Analysis

NPNK.F Stock Overview

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. More details

NPNK.F fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	1/6
Past Performance	4/6
Financial Health	6/6
Dividends	5/6

Rewards

Trading at 42.4% below our estimate of its fair value

Earnings are forecast to grow 6.81% per year

Earnings grew by 11.6% over the past year

Pays a reliable dividend of 2.15%

Risk Analysis

Shares are highly illiquid

Nippon Shinyaku Co., Ltd. Competitors

Supernus Pharmaceuticals

NasdaqGM:SUPN

US$2.0b

Amphastar Pharmaceuticals

NasdaqGS:AMPH

US$2.1b

Prestige Consumer Healthcare

NYSE:PBH

US$4.1b

Organon

NYSE:OGN

US$3.8b

Price History & Performance

Summary of all time highs, changes and price drops for Nippon Shinyaku
Historical stock prices
Current Share Price	JP¥41.82
52 Week High	JP¥56.45
52 Week Low	JP¥41.82
Beta	0.090
11 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	321.59%

Recent updates

Shareholder Returns

	NPNK.F	US Pharmaceuticals	US Market
7D	0%	-1.4%	0.3%
1Y	n/a	10.8%	31.1%

Return vs Industry: Insufficient data to determine how NPNK.F performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how NPNK.F performed against the US Market.

Price Volatility

Is NPNK.F's price volatile compared to industry and market?
NPNK.F volatility
NPNK.F Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	9.6%
Market Average Movement	6.2%
10% most volatile stocks in US Market	15.8%
10% least volatile stocks in US Market	3.1%

Stable Share Price: NPNK.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine NPNK.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1911	2,186	Toru Nakai	www.nippon-shinyaku.co.jp

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. Its Pharmaceuticals Business segment offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases.

Nippon Shinyaku Co., Ltd. Fundamentals Summary

How do Nippon Shinyaku's earnings and revenue compare to its market cap?
NPNK.F fundamental statistics
Market cap	US$2.51b
Earnings (TTM)	US$155.58m
Revenue (TTM)	US$971.48m

16.1x

P/E Ratio

2.6x

P/S Ratio

Is NPNK.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NPNK.F income statement (TTM)
Revenue	JP¥145.57b
Cost of Revenue	JP¥55.01b
Gross Profit	JP¥90.55b
Other Expenses	JP¥67.24b
Earnings	JP¥23.31b

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

Nov 13, 2023

Earnings per share (EPS)	346.12
Gross Margin	62.21%
Net Profit Margin	16.01%
Debt/Equity Ratio	0%

How did NPNK.F perform over the long term?

See historical performance and comparison

Dividends

2.1%

Current Dividend Yield

33%

Payout Ratio

Nippon Shinyaku OTCPK:NPNK.F Stock Report